Coronavirus India: Serum Institute’s vaccine export halt a ‘nightmare’ blow to Covax plan

India’s Serum Institute will suspend all coronavirus vaccine exports until around the end of the year amid the country health crisis, dealing a major blow to the global initiative to share jabs with poorer nations.The Covax Facility, a World Health Organization-backed programme, is depending on nearly 1 billion doses of the AstraZeneca shot that Serum Institute is licensed to make. The scheme had originally been expecting its biggest supplier to deliver 110 million doses by May.But India in…

Read the original article at South China Morning Post